Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4296854)

Published in Cancer Res Treat on August 21, 2014

Authors

Sun Min Lim1, Cheol Joo Yoo2, Jung Woo Han2, Yong Jin Cho3, Soo Hee Kim4, Joong Bae Ahn1, Sun Young Rha1, Sang Joon Shin1, Hyun Cheol Chung1, Woo Ick Yang4, Kyoo-Ho Shin3, Jae Kyung Rho1, Hyo Song Kim1

Author Affiliations

1: Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
2: Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.
3: Department of Orthopedic Surgery, Yonsei University College of Medicine, Seoul, Korea.
4: Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.

Articles cited by this

Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol (1998) 5.74

A system for the surgical staging of musculoskeletal sarcoma. 1980. Clin Orthop Relat Res (2003) 2.33

Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol (2009) 2.26

Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer (2003) 2.11

Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies. Cancer (2007) 1.93

Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer (2004) 1.75

Desmoplastic small round cell tumor: current management and recent findings. Sarcoma (2012) 1.68

The management of adult soft tissue sarcomas. Am J Clin Oncol (2009) 1.36

Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer (2010) 1.33

Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy. Cancer (2010) 1.20

Adult soft tissue Ewing sarcoma or primitive neuroectodermal tumors: predictors of survival? Arch Surg (2003) 1.16

Molecular classification of soft tissue sarcomas and its clinical applications. Int J Clin Exp Pathol (2010) 1.15

Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands. Neth J Med (2007) 1.10

Ewing sarcoma: clinical state-of-the-art. Pediatr Hematol Oncol (2012) 1.09

Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer (2004) 1.08

Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment. Jpn J Clin Oncol (2004) 1.03

Desmoplastic small round cell tumor: a clinical, pathological, and immunohistochemical study of 18 Chinese cases. Int J Surg Pathol (2008) 1.01

Rhabdomyosarcoma of the extremities and trunk: analysis of 150 patients treated by surgical resection. J Surg Oncol (1975) 0.89

Ewing sarcoma: its course and treatment in 50 adult patients. Oncology (1980) 0.88

Analysis of prognostic factors of pediatric-type sarcomas in adult patients. Oncology (2011) 0.86

Multidrug resistance proteins in rhabdomyosarcomas: comparison between children and adults. Cancer (2003) 0.81

Incidence and survival of pediatric soft tissue sarcomas in moscow region, Russian Federation, 2000-2009. Sarcoma (2012) 0.81

The challenge of access to care for soft tissue sarcomas bridging pediatric and adult age: the Italian pediatric oncology view. Expert Rev Anticancer Ther (2012) 0.78

Single center experience of treatment of Ewing's family of tumors in Japan. J Orthop Sci (2006) 0.76

Articles by these authors

Calretinin and microtubule-associated protein-2 (MAP-2) immunohistochemistry in the diagnosis of Hirschsprung's disease. J Pediatr Surg (2013) 0.85

Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma. BMC Cancer (2016) 0.83

Leiomyosarcoma: investigation of prognostic factors for risk-stratification model. Int J Clin Oncol (2015) 0.81

NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal. Oncotarget (2016) 0.81

Endothelial-to-mesenchymal transition induced by Wnt 3a in keloid pathogenesis. Wound Repair Regen (2015) 0.80

Characteristics of Cutaneous Lymphomas in Korea According to the New WHO-EORTC Classification: Report of a Nationwide Study. Korean J Pathol (2014) 0.80

Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites. Oncotarget (2016) 0.77

PTEN Methylation Dependent Sinonasal Mucosal Melanoma. Cancer Res Treat (2015) 0.76

Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas. J Pathol Transl Med (2016) 0.76

The prognostic significance of monoclonal immunoglobulin gene rearrangement in conjunction with histologic B-cell aggregates in the bone marrow of patients with diffuse large B-cell lymphoma. Cancer Med (2016) 0.76

Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma. Cancer Med (2017) 0.75

Prognostic implications of PIK3CA amplification in curatively resected liposarcoma. Oncotarget (2016) 0.75

Long Non-coding RNA HOTAIR Expression in Diffuse Large B-Cell Lymphoma: In Relation to Polycomb Repressive Complex Pathway Proteins and H3K27 Trimethylation. J Pathol Transl Med (2016) 0.75

Primary Cutaneous Adenoid Cystic Carcinoma Arising in Umbilicus. J Pathol Transl Med (2016) 0.75

Focal Lymphocytic Thyroiditis Nodules Share the Features of Papillary Thyroid Cancer on Ultrasound. Yonsei Med J (2015) 0.75

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial. Cancer Res Treat (2016) 0.75

Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08. Cancer Res Treat (2016) 0.75

The role and regulatory mechanism of 14-3-3 sigma in human breast cancer. J Breast Cancer (2014) 0.75

Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort. Cancer Res Treat (2016) 0.75

Soft Tissue Roasi-Dorfman Disease with Features of IgG4-Related Disease in a Patient with a History of Acute Myeloid Leukemia. J Pathol Transl Med (2015) 0.75

Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma. Oncotarget (2015) 0.75

Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcoma. APMIS (2017) 0.75

Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma. J Hepatol (2020) 0.75

Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea. Cancer Res Treat (2017) 0.75

Association of the long non-coding RNA MALAT1 with the polycomb repressive complex pathway in T and NK cell lymphoma. Oncotarget (2017) 0.75

Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration. J Surg Oncol (2016) 0.75

Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations. J Am Acad Dermatol (2019) 0.75

Pazopanib for the Treatment of Non-Clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study. Cancer Res Treat (2017) 0.75